Homepage   About us   Products   Capabilities   Clinical Development   Partners   Investor Relations   News & Events   Contact us     Press Releases Events Press Kit     Press Releases   2010 | 2009 | 2008 | 2007 | 2006 | Jan | Feb | Mar | Apr | Jun | Jul | Aug | Oct | Nov | Dec     Kamada Completes Enrollment in its Phase II Bronchiectasis Trial with Inhaled AAT December 16, 2008 Kamada (TASE; KMDA), a biopharmaceutical company engaged in the development, production and marketing of specialty life-saving biotherapeutics, announced today that it has completed patient enrollment in its Phase II clinical trial evaluating treatment of bronchiectasis patients with inhaled Alpha-... Click here to read the full Press Release         More Sign up to automatically receive e-mail alerts from Kamada     All rights reserved to Kamada © 2010 Terms and Conditions | Privacy Policy | Colours